Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Leukemia Clinical Trials

Protocol Number Title
1999LS060
MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2005LS036
MT2005-02 Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
MT2005-10 Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2005LS048
MT2004-24 Autologous Peripheral Blood Stem Cell Transplant for Patients with Lymphoma
2007LS024
MT2006-24 Total Marrow Irradiation and Myeloablative Chemotherapy Followed by Double Umbilical Cord Blood Transplantation in Patients with Refractory Acute Leukemia
2007NT102
COG AALL05B1: A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Samples.
2009NTLS130
Hematologic Malignancy Tissue Bank Formerly: "Leukemia, Lymphoma and MDS Tissue Bank" Formerly: "Leukemia and MDS Tissue Bank" & "Pediatric Leukemia Tissue Bank"
2009NTUC056
Childhood Cancer Survivor Study
2010LSUC043
MT2010-06 KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
2010NTCG113
COG AALL08B1 - Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
2011CG135
COG ACCL0933 - A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
2011CG161
COG AALL1131 - A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC 606869) in the Very High Risk Stratum Additional Title: Per Case Reimbursement NIH National Clinical Trials Network (NCTN) BIQSFP Grant U10CA180886-02S7 Add: AALL1131 Osteonecrosis Sub-study Per Case Reimbursement
2012CG016
MT2012-01 : A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologic Malignancies BMT CTN PROTOCOL 1101
2012CG099
COG ACCL1033 - A Comprehensive Approach to Improving Medication Compliance in Pediatric ALL
2012LS023
HM2013-12: IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation
2012LS089
MT2012-17R:Safety of Nplate? in Patients Who Have Failed to Achieve Platelet Engraftment Following Umbilical Cord Blood Transplant
2012NTLS024
MT2012-24R Preparative Regimen Exposure-Response Relationships in Nonmyeloablative Stem Cell Transplants: Correlative Pharmacokinetics.
2012NTLS130
MT2013-03R Impact of radiation therapy, gender and frailty on the geriatric hematopoietic cell transplant and advanced heme-malignancy population
2012OC065
MT2012-11C: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
2013LS081
Study of the ADAM17 Inhibitor INCB7839 Combined With Rituximab After Autologous Hematopoietic Cell Transplantation (HCT) For Patients With Diffuse Large B Cell Non-Hodgkin Lymphoma (DLBCL)
2013NTCG066
MT2014-01R Easy-to Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (CTN 1205)
2013NTLS082
Family-based studies of myeloid disorders and related conditions
2013NTUC039
BMT Long-Term Follow-up Study -2
2013OC003
MT2013-06C : Treatment of graft Failure after HSCT
2013OC116
MT2013-33C:REDUCED INTENSITY (RIC) CONDITIONING AND TRANSPLANTATION OF HLA-HAPLOIDENTICAL RELATED BONE MARROW (HAPLO-BM) FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2013UC004
MT2015-09R: A Phase II Randomized, Placebo-controlled, Multicenter Trial to Evaluate Protective Function of an Optimized Dose of CMVPepVax in Recipients of an Allogeneic Hematopoietic Stem Cell Transplant
2014CG017
MT2014-05R:A Multi-Center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls
2014CG089
COG AALL1231 - A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)
2014CG123
COG AALL1331 - Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) "AALL1331 - Amgen, Inc."
2014IS068
HM2015-05R : Novartis CCTL019B2206; HM2015-05R: A Multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial
2014IS078
HM2014-24: AN OPEN-LABEL PHASE 2 PROSPECTIVE,RANDOMIZED, CONTROLLED STUDY OF CLT-008 MYELOID PROGENITOR CELLS AS A SUPPORTIVE CARE MEASURE DURING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA
2014IS098
HM2015-03 : A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 versus Treatment Choice (TC) in Elderly Adults with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Remission Induction Therapy
2014LS092
MT2014-25: A Phase 2 Study of Subcutaneous Recombinant Human IL-15 (rhIL-15) and Haploidentical Donor Natural Killer (NK) Cell Infusion in Adults with Refractory or Relapsed Acute Myelogenous Leukemia
2014LS093
HM2014-26 DT2219 immunotoxin for the treatment of relapsed or refractory CD19 (+) and/or CD 22 (+) B-lineage leukemia or lymphoma
2014NTCG108
MT2015-02R: Randomized study of individualized care plans for hematopoietic cell transplant survivors
2014NTLS071
Family-based studies of susceptibility to early onset disease
2015EX073
Expanded Access, Single Patient Use of Inotuzumab for the Treatment of Relapsed Philadelphia Positive B-Cell Acute Lymphocytic Leukemia
2015IS033
HM2015-14: Novartis CCTL019B2202; A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia
2015NTIS093
MT2015-21R: A follow-up study that evaluates the safety and clinical outcomes of subjects who have undergone hematopoietic stem cell transplantation with HSC835 (expanded umbilical cord blood hematopoietic stem cells)
MT2006-13
MT2006-13 Autologous Peripheral Blood Stem Cell Transplant for Acute Non-Lymphocytic Leukemia (ANLL)
MT2011-28R
MT2011-28R: Assessment of Allogeneic Hematopoietic Stem Cell Transplantation in Medicare Beneficiaries with Myelodysplastic Syndrome and Related disorders - Part I.

42 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on